DarioHealth Corp [NASDAQ: DRIO] stock went on a downward path that fall over -12.45% on Tuesday, amounting to a one-week price decrease of less than -18.78%.
Over the last 12 months, DRIO stock dropped by -66.57%. The one-year DarioHealth Corp stock forecast points to a potential upside of 80.29. The average equity rating for DRIO stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $26.42 million, with 31.32 million shares outstanding and 28.62 million shares in the current float. Compared to the average trading volume of 185.02K shares, DRIO stock reached a trading volume of 16535511 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on DarioHealth Corp [DRIO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DRIO shares is $3.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DRIO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Alliance Global Partners have made an estimate for DarioHealth Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 13, 2022. While these analysts kept the previous recommendation, Cowen raised their target price to Outperform. The new note on the price target was released on April 22, 2021, representing the official price target for DarioHealth Corp stock. Previously, the target price had yet another raise to $30, while Stifel analysts kept a Buy rating on DRIO stock.
The Average True Range (ATR) for DarioHealth Corp is set at 0.21, with the Price to Sales ratio for DRIO stock in the period of the last 12 months amounting to 1.15. The Price to Book ratio for the last quarter was 0.37, with the Price to Cash per share for the same quarter was set at 0.43.
DRIO Stock Performance Analysis:
DarioHealth Corp [DRIO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -18.78. With this latest performance, DRIO shares dropped by -11.02% in over the last four-week period, additionally sinking by -52.28% over the last 6 months – not to mention a drop of -66.57% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DRIO stock in for the last two-week period is set at 45.52, with the RSI for the last a single of trading hit 43.51, and the three-weeks RSI is set at 46.31 for DarioHealth Corp [DRIO]. The present Moving Average for the last 50 days of trading for this stock 0.8115, while it was recorded at 0.9665 for the last single week of trading, and 1.0918 for the last 200 days.
Insight into DarioHealth Corp Fundamentals:
DarioHealth Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.32 and a Current Ratio set at 1.57.
DarioHealth Corp [DRIO] Institutonal Ownership Details
There are presently around $30.90%, or 40.08%% of DRIO stock, in the hands of institutional investors. The top three institutional holders of DRIO stocks are: NANTAHALA CAPITAL MANAGEMENT, LLC with ownership of 2.39 million shares, which is approximately 6.9429%. APPIAN WAY ASSET MANAGEMENT LP, holding 1.38 million shares of the stock with an approximate value of $$1.64 million in DRIO stocks shares; and APPIAN WAY ASSET MANAGEMENT LP, currently with $$1.34 million in DRIO stock with ownership which is approximately 3.2713%.